Effectiveness of Subcutaneous Tocilizumab in Neuromyelitis Optica spectrum disorders
Conclusions: Effectiveness of subcutaneous TCZ in NMOSD appears to be similar to that reported for the IV formulation and has an advantage of at-home administration. Prospective, comparative studies of subcutaneous TCZ for NMOSD are warranted.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Actemra | Arthritis | Brain | Disability | Multiple Sclerosis | Neurology | Rheumatoid Arthritis | Rheumatology | Study